"/> Novus Biologicals™ Peptide bloquant d’anticorps AN… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps ANAPC13

Réf. : BL-RE-045971Réf. fabricant : 18269425 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
25847
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76261. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acids near the center of human APC13.

Points forts

Source

Synthetic

(Accession #: NP_056206) The ANAPC13 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-045971
Réf. fabricant18269425
Gene ID (Entrez)25847
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76261. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneanaphase promoting complex subunit 13, anaphase-promoting complex subunit 13, APC13SWM1, cyclosome subunit 13, Cylosome subunit 13, DKFZP566D193, homolog of yeast Swm1
Symbole de gène(s)ANAPC13
Type de produitANAPC13
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids near the center of human APC13
Une question, une configuration particulière ?
Contactez-nous pour un devis.